BRCA2 and fallopian tube cancer: Whereas our estimation of the contribution of BRCA2 germline mutations for peritoneal/fallopian tube cancers in hospital-based cohorts is likely to be reliable, the evaluation of the contribution of BRCA1 mutations may require additional larger studies that include full gene analysis.